A recent study presented at the European Cancer Congress 2017 (ECCO 2017) in Amsterdam, the Netherlands, shows promise with a breath test measuring five chemicals in the detection of possible gastric and oesophageal cancers.
The improvement in overall survival (OS) among individuals given a combination of gemcitabine and capecitabine as adjuvant chemotherapy after surgically resected pancreatic adenocarcinoma highlights a potential new standard of care, according to findings of the phase III, open-label, multicentre ESPAC-4* trial.
Results from a study presented at the European Cancer Congress 2017 (ECCO 2017) in Amsterdam, the Netherlands showed that rapid deterioration of type 2 diabetes after diagnosis may be an early sign of pancreatic cancer.
Immunotherapy is hailed as clinical cancer advance of the year for the second year by the American Society of Clinical Oncology (ASCO).
Anxiety appears to be associated with increased mortality rate in non-small cell lung cancer (NSCLC) patients, according to a recent study.
Individuals diagnosed with thyroid cancer at a younger age have a higher risk of hypertension, swelling around the heart, and osteoporosis compared with individuals diagnosed at an older age, according to a study presented at the 2017 Cancer Survivorship Symposium (CSS 2017) held in San Diego, California, US.